These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 7596173

  • 1. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes.
    Galand P, Del Bino G, Morret M, Capel P, Degraef C, Fokan D, Feremans W.
    Leukemia; 1995 Jun; 9(6):1075-84. PubMed ID: 7596173
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues.
    Galand P, Degraef C.
    Cell Tissue Kinet; 1989 Sep; 22(5):383-92. PubMed ID: 2575456
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis.
    He W, Meyer JS, Scrivner DL, Koehm S, Hughes J.
    Biotech Histochem; 1994 Jul; 69(4):203-12. PubMed ID: 7918835
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Comparison with thymidine and bromodeoxyuridine labeling.
    Zeymer U, Fishbein MC, Forrester JS, Cercek B.
    Am J Pathol; 1992 Sep; 141(3):685-90. PubMed ID: 1381560
    [Abstract] [Full Text] [Related]

  • 8. Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki-67. A comparative study.
    Pelosi G, Bresaola E, Manfrin E, Rodella S, Schiavon I, Iannucci A.
    Arch Pathol Lab Med; 1994 May; 118(5):510-6. PubMed ID: 7910728
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM, Aung W, Sibbons PD, Howard CV, Clapham E, McGill F, Van Velzen D.
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [Abstract] [Full Text] [Related]

  • 11. Methodologies for the preservation of proliferation associated antigens PCNA, p120, and p105 in tumor cell lines for use in flow cytometry.
    Mikulka WR, Bolton WE.
    Cytometry; 1994 Nov 01; 17(3):246-57. PubMed ID: 7851160
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
    Goldblum JR, Shannon R, Kaldjian EP, Thiny M, Davenport R, Thompson N, Lloyd RV.
    Mod Pathol; 1993 Nov 01; 6(6):663-8. PubMed ID: 7508113
    [Abstract] [Full Text] [Related]

  • 13. Ki-67 immunostaining of normal human epidermis: comparison with 3H-thymidine labelling and PCNA immunostaining.
    Heenen M, Thiriar S, Noël JC, Galand P.
    Dermatology; 1998 Nov 01; 197(2):123-6. PubMed ID: 9732159
    [Abstract] [Full Text] [Related]

  • 14. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
    Khoshyomn S, Maier H, Morimura T, Kitz K, Budka H.
    Acta Neuropathol; 1993 Nov 01; 86(6):582-9. PubMed ID: 7906072
    [Abstract] [Full Text] [Related]

  • 15. Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.
    van Dierendonck JH, Wijsman JH, Keijzer R, van de Velde CJ, Cornelisse CJ.
    Am J Pathol; 1991 May 01; 138(5):1165-72. PubMed ID: 1673821
    [Abstract] [Full Text] [Related]

  • 16. Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNA.
    Budke H, Orazi A, Neiman RS, Cattoretti G, John K, Barberis M.
    Mod Pathol; 1994 Oct 01; 7(8):860-6. PubMed ID: 7838840
    [Abstract] [Full Text] [Related]

  • 17. Ki-S1 and PCNA expression in erythroid precursors and megakaryocytes--a comparative study on proliferative and endoreduplicative activity in reactive and neoplastic bone marrow lesions.
    Thiele J, Bertsch HP, Kracht LW, Anwander T, Zimmer JD, Kreipe H, Fischer R.
    J Pathol; 1994 May 01; 173(1):5-12. PubMed ID: 7523642
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies.
    Inoue T, Yamane T, Park K, Im T, Tatsumi N, Okuda K.
    Arch Pathol Lab Med; 1993 Oct 01; 117(10):969-72. PubMed ID: 8105766
    [Abstract] [Full Text] [Related]

  • 19. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
    Ghazvini S, Kroll S, Char DH, Frigillana H.
    Invest Ophthalmol Vis Sci; 1995 Dec 01; 36(13):2762-7. PubMed ID: 7499099
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.